Marksans Pharma Share price target & analyst calls
₹298.15-4.90 (-1.62%)
As of 21 Oct 2026
Only one active 1-year target
The long-term call is BUY₹36221.4% above today's price
Marksans Pharma has one active 1-year share price target: ₹362 from Axis Securities (31 Aug 2026). One target is a single view, not a consensus.
2
2 BUY · 0 SELL, all horizons
1
with an active 1Y target
40%
6 of 15 closed calls hit
18
all horizons, open and closed
Watch MARKSANS for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (18)
ASbyAxis Securities+21.4% to target
1 Year* · 10 mo left · 31 Aug 2026 · entry ₹321.6 · via Institutional / Brokerage ResearchP&L -7.3%
VbyVenturaTarget hit
1 Year* · 14 Mar 2024 · entry ₹144.35 · via Institutional / Brokerage Researchexit ₹301
CBbyChoice Broking+29.1% to target
1–3 Months* · 4 wk left · 18 Aug 2026 · entry ₹332 · via Economic Times Stock Recos OverviewP&L -10.2%
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 29 Sept 2026 · entry ₹345 · via IDBI Capital Research Calls Telegramexit ₹329
SRbySiddharth Rai MangalaExpired
1–3 Months* · 11 Jun 2026 · entry ₹255.03 · via Zee Business (Live)exit ₹330.4
AJbyAastha Jain, Hem SecuritiesTarget hit
1–2 Weeks* · 13 Aug 2026 · entry ₹313 · via Zee Business (Live)exit ₹330
RDbyRupak De, LKP SecuritiesTarget hit
1–2 Weeks · 5 Aug 2026 · entry ₹268.8 · via Business Todayexit ₹280
VKbyVishnu Kant Upadhyay, Master Capital ServicesStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹344 · via Business Todayexit ₹312
VRbyVinay Rajani, HDFC SecuritiesStop-loss hit
1–2 Weeks · 24 Sept 2026 · entry ₹345.8 · via NDTV Profit (Live)exit ₹326
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 24 Jun 2026 · entry ₹273 · via CNBC Awaaz.exit ₹262
KSbyKunal SaraogiStop-loss hit
Intraday* · 24 Sept 2026 · entry ₹345.8 · via Zee Business (Live)exit ₹340
KSbyKunal SaraogiStop-loss hit
Intraday* · 22 Sept 2026 · entry ₹340.05 · via Zee Business (Live)exit ₹332
KHbyKunal Hasmukhlal ShahExpired
Intraday* · 23 Sept 2026 · entry ₹341.2 · via Zee Business (Live)exit ₹348.5
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.1% · 19 calls
- CIPLACipla Ltd.₹1,524+16.0% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.5% · 15 calls
- BIOCONBiocon Ltd₹485+44.8% · 12 calls
- LUPINLupin Limited₹2,576+31.2% · 12 calls
- MARKSANS· this stockMarksans Pharma Limited₹362+21.4% · 1 call